Patent 9046513 was granted and assigned to AbbVie Inc. on June, 2015 by the United States Patent and Trademark Office.
Engineered multivalent and multispecific binding proteins, methods of making, and their uses in the prevention, diagnosis, and/or treatment of disease are provided.